Intermittent Metronomic Drug Schedule Is Essential for Activating Antitumor Innate Immunity and Tumor Xenograft Regression

Metronomic chemotherapy using cyclophosphamide (CPA) is widely associated with antiangiogenesis; however, recent studies implicate other immune-based mechanisms, including antitumor innate immunity, which can induce major tumor regression in implanted brain tumor models. This study demonstrates the...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Chen, Chong-Sheng, Doloff, Joshua C, Waxman, David J
Médium: Artigo
Jazyk:Inglês
Vydáno: Neoplasia Press Inc. 2014
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3924543/
https://ncbi.nlm.nih.gov/pubmed/24563621
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky